Scientific Advisory Board (SAB Sample Clauses

Scientific Advisory Board (SAB. ‌ An external Scientific Advisory Board (SAB) will be appointed and steered by the Network Steering Committee. The role of the SAB is to provide scientific advice to the NSC in support for the development of the Project objectives, strategy and activities. The SAB's terms of reference shall be not less stringent than those stipulated in this Consortium Agreement, and it shall be concluded no later than 30 calendar days after their nomination or before any confidential information will be exchanged, whichever date is earlier. The SAB will be composed of a maximum of 10 high-level experts in the field of translational cancer research who will be: - Proposed by the Network Steering Committee members; - Selected among outstanding internationally renowned independent experts in the field of translational cancer research; - Selected on the basis of their qualifications and capacity of experts and will not represent countries or regions; and, - Approved by the Network Steering Committee. There should be a good balance in terms of gender, age, regional and national representation, expertise and experience. Members will be required to provide written disclosure of any potential conflict of interest. SAB members cannot apply for the TRANSCAN-3 Joint Calls. In addition to the permanent SAB, ad-hoc Expert Groups can be appointed by the WPLs whenever necessary.
Sample 1
AutoNDA by SimpleDocs
Scientific Advisory Board (SAB. The SAB shall consist of five to seven members with staggered appointments of up to three years. The members of the SAB shall be prominent scientists to support the CSO in recruiting and assessing suitable scientists and optimizing the JVC's R&D activities.
Sample 1
Scientific Advisory Board (SAB. The SAB is a high-level body that advises on the scientific direction of the whole Flagship. It reports to the Legal Entity. Composition: Scientists at the top of disciplines of current and future interest to the HBP, but no participation or interest in the HBP. Members are nominated through a process determined by the GA / SB and then are appointed and dismissed by the GA / SB. The SAB will be initially appointed by the GA, upon signature of the FPA. When the Legal Entity becomes operational and the SB takes over from the GA as the HBP’s supreme decision- making body, the SB will have the opportunity to review composition of the SAB.
Sample 1
Scientific Advisory Board (SAB. The Scientific Advisory Board (SAB) complements the Consortium Bodies and will consist of international experts in the fields of seismology and earthquake engineering: − Prof. Xx. X. Zschau, Director of the Department Physics of the Earth at the Helmholtz Centre Potsdam GFZ, President of the European Seismological Commission (ESC) − Xx. X. Koller, President of the European Association for Earthquake Engineering (EAEE) − Prof. Xx. X. Pinto, Head of the Earthquake Engineering Section of the European Laboratory for Structural Assessment (XXXX) of the Joint Research Centre in Ispra, Italy − Prof. Xx. X. X. Xxxxx, Professor of Civil Engineering at the University of Rome “La Sapienza”, Chair of Earthquake Engineering, Department of Structural and Geotechnical Engineering The Scientific Advisory Board (SAB) monitors the progress of the project and advises the Management Committee and the Consortium on all issues of general scientific policy. It represents the interests of the wider scientific and engineering community and of key stakeholders in different sectors of the society, not covered by the Consortium. The SAB will meet annually with the Management Committee and the General Assembly to review project plans, progress, and results. Members of the SAB may be invited by the Coordinator on a case-by-case basis to attend meetings of the Management Committee or General Assembly. They will be bound by confidentiality obligations by signing a non-disclosure agreement, with obligations not less stringent than in this Consortium Agreement.
Sample 1
Scientific Advisory Board (SAB. The Scientific Advisory Board (SAB) monitors the progress of the project and advises the Management Committee and the Consortium on all issues of general scientific policy. It represents the interests of the wider scientific and engineering community and of key stakeholders in different sectors of the society, not covered by the Consortium. Its 4 members include key research figures in seismology and earthquake engineering. The composition of the Board will be finalized upon completion of the negotiation. The SAB will meet annually with the MC and the General Assembly to review project plans, progress, and results.
Sample 1

Related to Scientific Advisory Board (SAB

  • Advisory Board (a) The Managing Member may establish an Advisory Board comprised of members of the Managing Member’s expert network and external advisors. The Advisory Board will be available to provide guidance to the Managing Member on the strategy and progress of the Company. Additionally, the Advisory Board may: (i) be consulted with by the Managing Member in connection with the acquisition and disposal of a Series Asset, (ii) conduct an annual review of the Company’s acquisition policy, (iii) provide guidance with respect to, material conflicts arising or that are reasonably likely to arise with the Managing Member, on the one hand, and the Company, a Series or the Economic Members, on the other hand, or the Company or a Series, on the one hand, and another Series, on the other hand, (iv) approve any material transaction between the Company or a Series and the Managing Member or any of its Affiliates, another Series or an Economic Member (other than the purchase of interests in such Series), (v) provide guidance with respect to the appropriate levels of annual fleet level insurance costs and maintenance costs specific to each individual Series Asset, and review fees, expenses, assets, revenues and availability of funds for distribution with respect to each Series on an annual basis and (vi) approve any service providers appointed by the Managing Member in respect of the Series Assets.

  • Transition Committee 8.1.0 A transition committee comprised of the employee representatives and the employer representatives, including the Crown, will be established by January 31, 2016 to address all matters that may arise in the creation of the Trust.

  • Advisory Committee The Settling State shall designate an Opioid Settlement Remediation Advisory Committee (the “Advisory Committee”) to provide input and recommendations regarding remediation spending from that Settling State’s Abatement Accounts Fund. A Settling State may elect to use an existing advisory committee or similar entity (created outside of a State-Subdivision Agreement or Allocation Statute); provided, however, the Advisory Committee or similar entity shall meet the following requirements:

  • Audit Committee (A) The Audit Committee shall be composed of five members who shall be selected by the Board of Directors from its own members, none of whom shall be an officer of the Company, and shall hold office at the pleasure of the Board.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

  • Compensation Committee (A) The Compensation Committee shall be composed of not more than five (5) members who shall be selected by the Board of Directors from its own members who are not officers of the Company and who shall hold office during the pleasure of the Board.

  • Joint Commercialization Committee As of the Effective Date, the Parties have established a joint commercialization committee (the “Joint Commercialization Committee” or the “JCC”), composed of up to [ * ] representatives of each Party, to monitor and discuss the Commercialization of Products at the operational level. Each JCC representative shall have knowledge and expertise in the commercialization of products similar to Products. The JCC shall in particular:

  • Board Committees The Director hereby agrees to sit in the relevant committees of the Board and to perform all of the duties, services and responsibilities necessary thereunder.

Time is Money Join Law Insider Premium to draft better contracts faster.